ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
6,025.17
0.96%
US Tech 100
21,476.80
0.99%
Dow Jones
42,581.78
0.89%
Brent Oil
68.505
-1.93%
Bitcoin
105,164.87
-0.30%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Agentix Corporation (PK) (AGTX) Quote

Agentix Corporation (PK)

Agentix Corporation (PK) (AGTX)

USOTC
0.03229
0.00
(0.00%)
Closed June 24 4:00PM
15 min delayed - Upgrade to Realtime

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.03229
Bid
0.03229
Ask
0.03229
Volume
-
0.00 Day's Range 0.00
0.0213 52 Week Range 0.46
Market Cap
1.294M
Previous Close
0.03229
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
60,832
Shares Outstanding
40,066,951
Dividend Yield
-
PE Ratio
-2.05
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-585k

About Agentix Corporation (PK)

(OTC:AGTX), is a clinical-stage biotechnology company that is pursuing the development of a comprehensive suite of novel, science-driven, biopharmaceuticals that target the endocannabinoid system across multiple therapeutic areas with greater market exclusivity, for the treatment of metabolic diseas... (OTC:AGTX), is a clinical-stage biotechnology company that is pursuing the development of a comprehensive suite of novel, science-driven, biopharmaceuticals that target the endocannabinoid system across multiple therapeutic areas with greater market exclusivity, for the treatment of metabolic diseases; including Type 2 Diabetes Mellitus, Chronic Obesity, Non-alcoholic Fatty Liver Disease (NAFLD), and Non-alcoholic Steatohepatitis (NASH). AGENTIX acquired specific assets and licensing rights, including licensing rights associated with intellectual property as part of Worldwide Exclusive Agreements with NHRI (National Heath Research Institute) and RTI (Research Triangle Institute) International. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.agentixcorp.com
Headquarters
Carson City, Nevada, USA
Founded
-
Agentix Corporation (PK) is listed in the Biological Pds,ex Diagnstics sector of the OTCMarkets with ticker AGTX. The last closing price for Agentix (PK) was $0.03. Over the last year, Agentix (PK) shares have traded in a share price range of $ 0.0213 to $ 0.46.

Agentix (PK) currently has 40,066,951 shares outstanding. The market capitalization of Agentix (PK) is $1.29 million. Agentix (PK) has a price to earnings ratio (PE ratio) of -2.05.

Ask ADVFN Intelligence (AI)

AGTX Latest News

More News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
February 18 2025
AGTX (0.00%)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Edgar (US Regulatory)
February 14 2025
AGTX (0.00%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
November 18 2024
AGTX (0.00%)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Edgar (US Regulatory)
November 14 2024
AGTX (0.00%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
August 30 2024
AGTX (0.00%)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Edgar (US Regulatory)
August 15 2024
AGTX (0.00%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
February 14 2024
AGTX (0.00%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
November 20 2023
AGTX (0.00%)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Edgar (US Regulatory)
November 14 2023
AGTX (0.00%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
August 22 2023
AGTX (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.032290.032290.032295000.03229CS
4-0.00771-19.2750.040.050.0213992320.02772845CS
12-0.02021-38.49523809520.05250.06980.0213608320.03067068CS
26-0.12781-79.83135540290.16010.19660.0213295880.05121858CS
52-0.00771-19.2750.040.460.0213253960.07765733CS
156-0.12581-79.57621758380.15810.460.021172240.07415964CS
260-2.03771-98.44009661842.0750.000189930.18747968CS

AGTX - Frequently Asked Questions (FAQ)

What is the current Agentix (PK) share price?
The current share price of Agentix (PK) is $ 0.03229
How many Agentix (PK) shares are in issue?
Agentix (PK) has 40,066,951 shares in issue
What is the market cap of Agentix (PK)?
The market capitalisation of Agentix (PK) is USD 1.29M
What is the 1 year trading range for Agentix (PK) share price?
Agentix (PK) has traded in the range of $ 0.0213 to $ 0.46 during the past year
What is the PE ratio of Agentix (PK)?
The price to earnings ratio of Agentix (PK) is -2.05
What is the reporting currency for Agentix (PK)?
Agentix (PK) reports financial results in USD
What is the latest annual profit for Agentix (PK)?
The latest annual profit of Agentix (PK) is USD -585k
What is the registered address of Agentix (PK)?
The registered address for Agentix (PK) is 112 NORTH CURRY STREET, CARSON CITY, NEVADA, 89703 4934
What is the Agentix (PK) website address?
The website address for Agentix (PK) is www.agentixcorp.com
Which industry sector does Agentix (PK) operate in?
Agentix (PK) operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AACAFAAC Technologies Holdings Inc (PK)
$ 4.53
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.0263
(0.00%)
0
AABKFAareal Bank AG (CE)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0308
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AACAFAAC Technologies Holdings Inc (PK)
$ 4.53
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.0263
(0.00%)
0
AABKFAareal Bank AG (CE)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0308
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AACAFAAC Technologies Holdings Inc (PK)
$ 4.53
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.0263
(0.00%)
0
AABKFAareal Bank AG (CE)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0308
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0

Discussion

View Full Feed
ErnieBilco ErnieBilco 4 minutes ago
23 June 2025

London Stock Exchange---------CBOE BXE-----------CBOE CXE--------Aquis
---------404,590-----------------------422,267----------------110,694----------55,082
RYCEY
threewheeler threewheeler 4 minutes ago
yeap its about the top function on here, cant even tell u how many hundred posters are on my list, but its great u only need to iggy them once and it doesnt matter what board they post on, still iggied, makes IHub actually read able
AHRO
x993231 x993231 4 minutes ago
Remember though that there are 10 million extra shares on loan, that are not reported as shorted.  Those shares could be in the hands of shorts to play, or perhaps they are borrowed by an organization or individual that wants to force something.  The shorts that are short want to keep carrying cost
LWLG
makinezmoney makinezmoney 6 minutes ago
$NA: Just amazing........... now $22

3 weeks still running higher from a start of $3.50


WOW wwaaaaa weee wwwwwahhhhhhhhhhhhhh


GO $NA
NA
boi568 boi568 6 minutes ago
120 of those review days have already passed -- and that review clock is stopped right now while Anavex is preparing a response to reviewer questions. So the variable is Anavex, and then there are up to 90 days of additional EMA review and a potential second clock stop before the EMA issues a go or
AVXL
DMC8 DMC8 7 minutes ago
https://www.stocktitan.net/news/AMRN/amarin-announces-exclusive-license-and-supply-agreement-with-0ym8l9gnpaef.html
AMRN
threewheeler threewheeler 7 minutes ago
AZRH looking forward to getting more info from Controled as 3 more posts no one sees, will be entertain as are all the responses blowing up fake posts with real facts
AZRH
Nelson2 Nelson2 7 minutes ago
Well, boyz time for the verdict
A stroke of luck with ceasefire announcement. Up premarket
Now let’s run like a raped ape at the open!

GLTA
BB
subslover subslover 10 minutes ago
SunHydrogen to Deploy more than 30 m² Hydrogen Production Pilot System in Collaboration with UT Austin
First large-scale multi-panel solar-to-hydrogen system to be installed at UT Austin’s Hydrogen ProtoHub, featuring sixteen photoelectrochemical hydrogen reactors totaling more than 30m² in a
HYSR
Monksdream Monksdream 11 minutes ago
Nano Labs Announces US$500 Million Convertible Notes Private Placement for BNB Treasury Strategy
June 24 2025 - 6:00AM

Alert
Print
Share On Facebook

Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading Web 3.0 infrastructure
nyt nyt 11 minutes ago
Nothing more than just another of the many many monkey wrenches I've predicted and have manifested for yrs and yrs that never, I repeat, NEVER, amount to anything of substance. Reason being there is no substance. Vplm, in all its glory is nothing more than dryer fluff, pocket lint, the daily trash.
VPLM
makinezmoney makinezmoney 12 minutes ago
$INM: Awaaayyyyyyy she goes.... now $4.50

Big premarket booster from just 2.50

NICEEeeeeeeeeeeeeeeeeeeeee


GO $INM
INM
Monksdream Monksdream 13 minutes ago
INM
INM
GoodGuyBill GoodGuyBill 14 minutes ago
Most people who disagree with a particular claim do so by presenting counter arguments not baseless personal attacks. This response to a reasonable post lakes any credibility whatsoever. I don't understand how posts like this-- referring to people as liars, are allowed. TOS violation?
NWBO
pepeoil pepeoil 14 minutes ago
Oh yea Joshy, I don’t see you on the Texas RRC approved pluggers list. You can’t do it yourself. Bwahaaaaaa. You have to hire someone to come crush your cement. Bwahaaaaa.
AZRH
Scotty9 Scotty9 14 minutes ago
O my prophet what else do you see in the tickers please tell us all
TWOH
Monksdream Monksdream 15 minutes ago
iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results
June 24 2025 - 7:00AM

Alert
Print
Share On Facebook

iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of next-generation antibody
IBIO
Investor2014 Investor2014 17 minutes ago
We have no idea and just invest because it all sounds cool or believe TA will tell us, so you seem to have joined the right party.
AVXL
Monksdream Monksdream 17 minutes ago
Top 15
https://www.advfn.com/markets/nasdaq/premarket
JayB2022 JayB2022 18 minutes ago
NTRR
Cameo Brien Cameo Brien 19 minutes ago
Current Price: ~$0.58 (as of June 23, 2025)  
52-Week Range: $0.22 – $1.05  
Market Cap: Approximately $75–80?million  
Average Daily Volume: ~150,000 shares  
Real-time Volatility & Movers: +7–12% intraday moves not uncommon 
AVAI
jimmybob jimmybob 22 minutes ago
GM FOLKSSS
hedge_fun hedge_fun 23 minutes ago
This is the future and the robots are…….

coming as well, which is what is driving the share price.

Happy Taco Tuesday!
TSLA
stocktowatch stocktowatch 25 minutes ago
$GNLX Update! Preliminary data from Genelux’s Phase 1b trial in platinum-relapsed/refractory small cell lung cancer (SCLC) shows early promise for Olvi-Vec immunochemotherapy.
https://x.com/Genelux_Corp/status/1937231860674744489
GNLX
bigrun bigrun 25 minutes ago
Did you buy this at 0.009 and sold at 0.003….???? Lmfao
TWOH

Your Recent History

USOTC
AGTX
Agentix (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads